Nasdaq
GHRS
GH Research PLC
- Health Care
- Ireland
- Listed 2021
- 1 day
- +5.2%
- 1 month
- +13.9%
- 1 year
- +152%
$30.64 · Mkt cap $2.10B
At the 6 Aug 2026 close
Nasdaq
GH Research PLC
$30.64 · Mkt cap $2.10B
At the 6 Aug 2026 close
GH Research PLC trades under the ticker GHRS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $2.10B. The last closing price was $30.64, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +152%, and +13.9% over the past month. Returns are price returns and exclude dividends.
This page exists because GHRS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.